{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:38:07Z","timestamp":1782603487199,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-024-07895-3","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T15:45:21Z","timestamp":1734795921000},"page":"175-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of pyridostigmine on growth hormone and IGF-1 levels and outcomes of controlled ovarian stimulation cycle in women with poor ovarian response"],"prefix":"10.1007","volume":"311","clinical-trial-number":[{"clinical-trial-number":"irct20100518003950n8","registry":"10.18810\/irct"}],"author":[{"given":"Rana","family":"Karimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Hadavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Jafarabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"key":"7895_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead184","author":"K Lundin","year":"2023","unstructured":"Lundin K, Bentzen JG, Bozdag G et al (2023) Good practice recommendations on add-ons in reproductive medicine. Human Reprod. https:\/\/doi.org\/10.1093\/humrep\/dead184","journal-title":"Human Reprod"},{"key":"7895_CR2","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1007\/s43032-020-00298-0","volume":"28","author":"FT Liu","year":"2021","unstructured":"Liu FT, Hu KL, Li R (2021) Effects of growth hormone supplementation on poor ovarian responders in assisted reproductive technology: a systematic review and meta-analysis. Reprod Sci 28:936\u2013948","journal-title":"Reprod Sci"},{"key":"7895_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.03.007","author":"M Cozzolino","year":"2020","unstructured":"Cozzolino M, Cecchino GN, Troiano G, Romanelli C (2020) Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: a systematic review and meta-analysis. Fertil Steril. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.03.007","journal-title":"Fertil Steril"},{"key":"7895_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1054\/ghir.2002.0265","volume":"12","author":"JJ Kim","year":"2002","unstructured":"Kim JJ, Accili D (2002) Signalling through IGF-I and insulin receptors: where is the specificity? Growth Hormone IGF Res 12:84\u201390","journal-title":"Growth Hormone IGF Res"},{"key":"7895_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/joe.0.1680001","volume":"168","author":"KL Hull","year":"2001","unstructured":"Hull KL, Harvey S (2001) Growth hormone: roles in female reproduction. J Endocrinol 168:1\u201323","journal-title":"J Endocrinol"},{"key":"7895_CR6","doi-asserted-by":"publisher","DOI":"10.1210\/en.2017-03175","author":"MJ Lecomte","year":"2018","unstructured":"Lecomte MJ, Bertolus C, Ramanantsoa N et al (2018) Acetylcholine modulates the hormones of the growth hormone\/insulinlike growth factor-1 axis during development in mice. Endocrinology. https:\/\/doi.org\/10.1210\/en.2017-03175","journal-title":"Endocrinology"},{"key":"7895_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.1990.tb00428.x","author":"E Freeman","year":"1990","unstructured":"Freeman E, Touzel R, Grossman A et al (1990) Pyridostigmine, an acetylcholinesterase inhibitor, stimulates growth hormone release, but has no effect on basal thyrotrophin or adrenocorticotrophin levels, or the thyrotrophin response to thyrotrophin-releasing hormone. J Neuroendocrinol. https:\/\/doi.org\/10.1111\/j.1365-2826.1990.tb00428.x","journal-title":"J Neuroendocrinol"},{"key":"7895_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.9790\/0853-1804136167","volume":"18","author":"MHN Al-Din","year":"2019","unstructured":"Al-Din MHN, Harb HM, Mostafa MH, Hussein MR (2019) Effect of pyridostigmine on ovulation rate in clomiphene-resistant PCOS women. IOSR J Dent Med Sci 18:61\u201367. https:\/\/doi.org\/10.9790\/0853-1804136167","journal-title":"IOSR J Dent Med Sci"},{"key":"7895_CR9","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","volume":"105","author":"C Alviggi","year":"2016","unstructured":"Alviggi C, Andersen CY, Buehler K et al (2016) A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril 105:1452\u20131453","journal-title":"Fertil Steril"},{"key":"7895_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)57556-6","author":"JA Rock","year":"1995","unstructured":"Rock JA, Aiman EJ, Barad DH et al (1995) The revised American fertility society classification of endometriosis: reproducibility of scoring. Fertil Steril. https:\/\/doi.org\/10.1016\/s0015-0282(16)57556-6","journal-title":"Fertil Steril"},{"key":"7895_CR11","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00404-022-06565-6","volume":"307","author":"M Di","year":"2023","unstructured":"Di M, Wang X, Wu J, Yang H (2023) Ovarian stimulation protocols for poor ovarian responders: a network meta-analysis of randomized controlled trials. Arch Gynecol Obstet 307:1713\u20131726","journal-title":"Arch Gynecol Obstet"},{"key":"7895_CR12","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/HUMREP\/DEX234","volume":"32","author":"F Zegers-Hochschild","year":"2017","unstructured":"Zegers-Hochschild F, Adamson GD, Dyer S et al (2017) The international glossary on infertility and fertility care, 2017. Hum Reprod 32:1786\u20131801. https:\/\/doi.org\/10.1093\/HUMREP\/DEX234","journal-title":"Hum Reprod"},{"key":"7895_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(98)00527-5","author":"CH Kim","year":"1999","unstructured":"Kim CH, Chae HD, Chang YS (1999) Pyridostigmine cotreatment for controlled ovarian hyperstimulation in low responders undergoing in vitro fertilization-embryo transfer. Fertil Steril. https:\/\/doi.org\/10.1016\/S0015-0282(98)00527-5","journal-title":"Fertil Steril"},{"key":"7895_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/12.10.2123","author":"A Juul","year":"1997","unstructured":"Juul A, Scheike T, Pedersen AT et al (1997) Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle. Human Reprod. https:\/\/doi.org\/10.1093\/humrep\/12.10.2123","journal-title":"Human Reprod"},{"key":"7895_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)54415-x","author":"BA Stone","year":"1991","unstructured":"Stone BA, Marrs RP (1991) Growth hormone in serum of women during the menstrual cycle and during controlled ovarian hyperstimulation. Fertil Steril. https:\/\/doi.org\/10.1016\/s0015-0282(16)54415-x","journal-title":"Fertil Steril"},{"key":"7895_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb02270.x","author":"ACS Faria","year":"1992","unstructured":"Faria ACS, Bekenstein LW, Booth RA et al (1992) Pulsatile growth hormone release in normal women during the menstrual cycle. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/j.1365-2265.1992.tb02270.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"7895_CR17","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.5.4761","author":"P Ovesen","year":"1998","unstructured":"Ovesen P, Vahl N, Fisker S et al (1998) Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.83.5.4761","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07895-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-024-07895-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07895-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T11:08:25Z","timestamp":1739358505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-024-07895-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["7895"],"URL":"https:\/\/doi.org\/10.1007\/s00404-024-07895-3","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,21]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was designed and performed according to the Declaration of Helsinki. The study protocol was approved by the ethics committee of Imam Khomeini Hospital Complex-Tehran University of Medical Sciences (reference number: IR.TUMS.IKHC.REC.1402.173, approval date: 2023-07-19).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided informed written consent before enrollment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The trial was registered with the Iranian Registry of Clinical Trials (registration number: IRCT20100518003950N8; registration date: 2023-08).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registry"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}